Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Other Non-Current Assets of $2.0 million for Q1 2026, up 6.73% year-over-year from $1.9 million in Q1 2025, and up 40.22% quarter-over-quarter from $1.4 million in Q4 2025.

Analysis

Shattuck Labs (STTK) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Other Non-Current Assets for 8 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 6.73% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 6.73% YoY), while the FY2025 annual figure was $1.4 million, down 28.93% from the prior year.
  • Other Non-Current Assets rose to $2.0 million in Q1 2026 per STTK's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $3.2 million in Q1 2022 and bottomed at $1.4 million in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $2.5 million in 2023.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 1066.67% — and 2025, when it fell 28.93%.
  • Shattuck Labs' Other Non-Current Assets stood at $3.1 million in 2022, then retreated by 17.24% to $2.5 million in 2023, then dropped by 20.39% to $2.0 million in 2024, then retreated by 28.93% to $1.4 million in 2025, then jumped by 40.22% to $2.0 million in 2026.
  • Business Quant data shows STTK's Other Non-Current Assets at $2.0 million in Q1 2026, $1.4 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - 1.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.88 Mn
Mar 31, 2026 2.02 Mn
Dec 31, 2025 1.44 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 1.75 Mn
Mar 31, 2025 1.89 Mn
Dec 31, 2024 2.02 Mn
Sep 30, 2024 2.15 Mn
Jun 30, 2024 2.29 Mn
Mar 31, 2024 2.43 Mn
Dec 31, 2023 2.54 Mn
Sep 30, 2023 2.67 Mn
Jun 30, 2023 2.81 Mn
Mar 31, 2023 2.95 Mn
Dec 31, 2022 3.07 Mn
Sep 30, 2022 3.19 Mn
Jun 30, 2022 3.16 Mn
Mar 31, 2022 3.23 Mn
Dec 31, 2021 381,000.00
Sep 30, 2021 273,000.00